Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603. State of the Art and Science May 2016 Health Care Ethics Consultation via Telemedicine: Linking Expert Clinical Ethicists and Local Consultants Alexander A. Kon, MD and Maj. Robert J. Walter, MD, DHCE Successful telemedicine ethics consultation requires knowledge of relevant laws and, for videoconferences, the physical presence of a meeting leader. AMA J Ethics. 2016;18(5):514-520. doi: 10.1001/journalofethics.2016.18.5.stas1-1605. State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605. Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865. Medical Education Jun 2016 Healing Medicine’s Future: Prioritizing Physician Trainee Mental Health Kathryn Baker, MD and Srijan Sen, MD, PhD High rates of burnout and depression among residents underscore the need for innovative ways to promote wellness, mental health awareness. AMA J Ethics. 2016;18(6):604-613. doi: 10.1001/journalofethics.2016.18.6.medu1-1606. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603.
State of the Art and Science May 2016 Health Care Ethics Consultation via Telemedicine: Linking Expert Clinical Ethicists and Local Consultants Alexander A. Kon, MD and Maj. Robert J. Walter, MD, DHCE Successful telemedicine ethics consultation requires knowledge of relevant laws and, for videoconferences, the physical presence of a meeting leader. AMA J Ethics. 2016;18(5):514-520. doi: 10.1001/journalofethics.2016.18.5.stas1-1605.
State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605.
Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865.
Medical Education Jun 2016 Healing Medicine’s Future: Prioritizing Physician Trainee Mental Health Kathryn Baker, MD and Srijan Sen, MD, PhD High rates of burnout and depression among residents underscore the need for innovative ways to promote wellness, mental health awareness. AMA J Ethics. 2016;18(6):604-613. doi: 10.1001/journalofethics.2016.18.6.medu1-1606.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.